Abbott Laboratories
ABT
#58
Rank
NZ$384.48 B
Marketcap
NZ$220.99
Share price
-0.03%
Change (1 day)
30.43%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

Abbott Laboratories (ABT) - Net assets

Net assets on the balance sheet as of March 2025 : NZ$82.51 Billion

According to Abbott Laboratories's latest financial reports the company has NZ$82.51 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Abbott Laboratories - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$84.93 B38.34%
2023-12-31$NZ$61.39 B5.62%
2022-12-31$NZ$58.12 B10.21%
2021-12-31$NZ$52.74 B15.31%
2020-12-31$NZ$45.73 B-1.59%
2019-12-31$NZ$46.47 B1.48%
2018-12-31$NZ$45.80 B4.6%
2017-12-31$NZ$43.78 B46.41%
2016-12-31$NZ$29.90 B-4.02%
2015-12-31$NZ$31.15 B12.82%
2014-12-31$NZ$27.61 B-10.18%
2013-12-31$NZ$30.74 B-5.67%
2012-12-31$NZ$32.59 B3.72%
2011-12-31$NZ$31.42 B6.5%
2010-12-31$NZ$29.50 B-6.4%
2009-12-31$NZ$31.52 B4.43%
2008-12-31$NZ$30.18 B30.07%
2007-12-31$NZ$23.20 B16.35%
2006-12-31$NZ$19.94 B-5.41%
2005-12-31$NZ$21.09 B5.05%
2004-12-31$NZ$20.07 B-0.16%
2003-12-31$NZ$20.10 B-1.31%
2002-12-31$NZ$20.37 B-6.6%
2001-12-31$NZ$21.81 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$131.36 B 59.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$152.43 B 84.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$83.22 B 0.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$7.76 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$81.15 B-1.65%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Bristol-Myers Squibb
BMY
NZ$29.34 B-64.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$37.74 B-54.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$69.17 B-16.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$64.66 B-21.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$29.67 B-64.04%๐Ÿ‡ฌ๐Ÿ‡ง UK